Overview
Key facts
- UCL's Regulatory Science for Advanced (Gene and Cell) Therapies course plans to have CPD approval by the Royal College of Pathologists.
- It's aimed at those in a wide range of roles that regularly face challenges in production, testing and registration of advanced therapy medicinal products (ATMPs).
Programme Structure
Courses include:
- Reveal up-to-date gene/cell therapy development, production technology and regulation.
- Clarify ethics, clinical trial designs and commercial licensing issues.
Key information
Duration
- Full-time
- 2 days
Start dates & application deadlines
Language
Delivered
Campus Location
- London, United Kingdom
Disciplines
Molecular Sciences Genetics View 8 other Short Courses in Genetics in United KingdomWhat students do after studying
Academic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
This course is for anyone interested in the translational side of gene and cell therapy.
It will be particularly useful for those involved in producing, testing and registering ATMPs.
We welcome interest from:
- staff at pharmaceutical companies or SMEs
- staff at regulatory authorities (e.g. MHRA, Public Health England, Department of Health and equivalents from other countries)
- national ethics services (NRES in UK)
- academic clinicians and allied health professionals from research hospitals
- scientists and students from other universities and other academic institutions
Tuition Fees
Living costs
London
The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.